CATALYST ONCOLOGY
Catalyst Oncology is a full-service, specialty contract research organization (CRO) built to serve the global biotech industry. Backed by leading retention rates and a culture rooted in its core values, Catalyst Oncology provides customers with teams experienced across all functions, knowledgeable in complex drug classes and study designs, and with data-centric methodologies that help bring next-generation therapies to cancer patients. Connect with Catalyst Oncology on LinkedIn.
FEATURED ARTICLES
-
![GettyImages-2179548801-ADC-3d-render]( "The Resurgence Of Antibody-Drug Conjugates")
As advancements in ADC technology and clinical trial methodologies progress, Antibody-Drug Conjugates (ADCs) are poised to become pivotal in precision oncology.
-
![GettyImages-1663374966-lab-microscope-mask-research-study]( "Navigating Project Optimus And The Rapidly Changing Oncology Development Landscape")
Project Optimus and adaptive trial designs are reshaping oncology development, improving patient outcomes, and streamlining approval pathways.
-
![GettyImages-1175131167 cancer]( "Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies")
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
-
![GettyImages-2169869893-business-woman-office-building-team-table]( "Optimizing Global Early-Phase Oncology Trials")
By integrating strong partnerships, local expertise, and predictive analytics, sponsors and CROs can identify and activate the most suitable sites, accelerating trial delivery.
CONTACT INFORMATION
Catalyst Oncology
2528 Independence Blvd, Suite 100,
Wilmington, NC 28412
UNITED STATES
Phone: 1.919.648.0668
FEATURED SOLUTIONS
-
![GettyImages-2152658176 oncology, doctor, patient]( "Oncology CRO Helping To Bring Cancer Therapies To Patients")
Niche CRO with a difference
Catalyst Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
CASE STUDIES
-
![Cancer patient consulting with doctor-GettyImages-1217056000]( "Accelerating Approval Pathway For Phase III Ovarian Cancer Trial")
A late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.
